Go to the page content
reimagine-waves-image1

Ongoing clinical studies

The programme consists of 4 global clinical studies, some of which might be happening in your country.

You can find more information about the studies running in your country below:

   

A study to compare the effect on blood sugar levels and weight in people living with type 2 diabetes and overweight. The study will compare the study medicine to Its two individual components (the antidiabetic medication and the medicine under development)

   

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.

HQ23DI00119

Novo Nordisk (Pty) Ltd. Reg. No.: 1959/000833/07. 150 Rivonia Road, 10 Marion Street Office Park, Building C1, Sandton, Johannesburg, 2196.
Tel: (011) 202 0500 Fax: (011) 807 7989. www.novonordisk.com. COMPONENT-046457 March 2024